Svensson M et al. |
Pharmacodynamic effects of nitroimidazoles alone and in combination with clarithromycin on Helicobacter pylori. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12069981
|
Gibreel A et al. |
Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17606685
|
Comley JC and Sterling AM |
Effect of atovaquone and atovaquone drug combinations on prophylaxis of Pneumocystis carinii pneumonia in SCID mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785975
|
Watanabe K et al. |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561829
|
Struillou L et al. |
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7785988
|
Endo H et al. |
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11709323
|
Taylor DE et al. |
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9420030
|
Nash KA and Inderlied CB |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8592991
|
Cho SH et al. |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17210775
|
Ji B et al. |
Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17664316
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Bakker-Woudenberg IA et al. |
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917538
|
Traunmüller F et al. |
Pharmacokinetics of single- and multiple-dose oral clarithromycin in soft tissues determined by microdialysis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17606673
|
Kim YC et al. |
Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917564
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Kalach N et al. |
Clarithromycin resistance and eradication of Helicobacter pylori in children. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11408237
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Koh WJ et al. |
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25987622
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Inderlied CB et al. |
Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986017
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Bermudez LE et al. |
Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986018
|
Khan AA et al. |
Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145840
|
Collins L and Franzblau SG |
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145860
|
Lounis N et al. |
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9145892
|
Osborne CS et al. |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19596876
|
Bosnar M et al. |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917536
|
Hardy DJ et al. |
Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2143642
|
Subramanian S et al. |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18070962
|
Moon JE et al. |
Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16723556
|
Burton AJ et al. |
Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25824218
|
Leuthner KD et al. |
Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16436754
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Cirioni O et al. |
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18779356
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Abduljalil K et al. |
Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19414584
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Bermudez LE et al. |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695252
|
Mor N et al. |
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695255
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Clark CL et al. |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876003
|
Lacassin F et al. |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695324
|
Amsden GW et al. |
Oral cimetidine prolongs clarithromycin absorption. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9660986
|
Liou JM et al. |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21189342
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Bae S et al. |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19884366
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Spyridaki A et al. |
Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22564837
|
Stone GG et al. |
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9056021
|
Furuie H et al. |
Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19933801
|
Tessier PR et al. |
Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. |
2002 |
Antimicrob. Agents Chemother. |
pmid:11959578
|
Ichiyama T et al. |
Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120942
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Nakamura S et al. |
Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19949056
|
Bermudez LE et al. |
Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22615290
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Jorgensen JH et al. |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834012
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Jesus FP et al. |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26459895
|
Andini N and Nash KA |
Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16801446
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
van Doorn LJ et al. |
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302817
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Piccolomini R et al. |
In vitro activity of clarithromycin against intracellular Helicobacter pylori. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302831
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Secka O et al. |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23263004
|
Fernandes PB et al. |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. |
1986 |
Antimicrob. Agents Chemother. |
pmid:2949695
|
Segreti J et al. |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952061
|
Benson CA et al. |
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952063
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Barry AL et al. |
In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2952064
|
Ji B et al. |
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482155
|
Chin NX et al. |
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2953303
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Rastogi N and Goh KS |
Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1482156
|
Matsuzaki J et al. |
Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22203601
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Giamarellos-Bourboulis EJ et al. |
Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa. |
2004 |
Antimicrob. Agents Chemother. |
pmid:14693524
|
Hultén K et al. |
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371366
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Yamazaki T et al. |
Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17387152
|
Bogdanovich T et al. |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16495248
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Welsh L et al. |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787907
|
Valero G et al. |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872769
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|
Cohen Y et al. |
Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793882
|
Renvoisé A et al. |
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26324275
|
Nash KA |
Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506008
|
Best LM et al. |
Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506021
|